Evidence map›Paper›PMID 21091637›Full record

ReviewActa physiologica (Oxford, England)2011

NAD+ depletion or PAR polymer formation: which plays the role of executioner in ischaemic cell death?

C Siegel, L D McCullough

Abstract readReview
In one paragraph

Review in Acta physiologica (Oxford, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Increasing adult-born neurons protects mice from epilepsy.bioRxiv : the preprint server for biology · 2024
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Novel directions for diabetes mellitus drug discovery.Expert opinion on drug discovery · 2013
    Review
  17. Article
  18. Article
  19. A dual role for poly(ADP-ribose) polymerase-1 during caspase-dependent apoptosis.Toxicological sciences : an official journal of the Society of Toxicology · 2012
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

C SiegelDepartment of Neuroscience, University of Connecticut Health Center, Farmington, 06030, USA.
L D McCullough
UConn Health · US

Funding

Gender Differences in Ischemic Cell DeathR01NS055215 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCCULLOUGH, LOUISE D. · 2007 to 2016
$4.3M
Neuroscience Training at University of Connecticut Health CenterT32NS041224 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI EIPPER, ELIZABETH ANNE · 2001 to 2010
$1.3M
Investigation of underlying mechanisms of sex differences in cerebral ischemiaF31NS062608 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI SIEGEL, CHAD S · 2008 to 2010
$87k
NINDS NIH HHS 1R01-NS055215NINDS NIH HHS 5F31-NS062608-02NINDS NIH HHS 5T32-NS041224-08NINDS NIH HHS F31 NS062608NINDS NIH HHS R01 NS055215NINDS NIH HHS T32 NS041224PHS HHS NSO50505
6 · The paper itself

Abstract

Multiple cell death pathways are activated in cerebral ischaemia. Much of the initial injury, especially in the core of the infarct where cerebral blood flow is severely reduced, is necrotic and secondary to severe energy failure. However, there is considerable evidence that delayed cell death continues for several days, primarily in the penumbral region. As reperfusion therapies grow in number and effectiveness, restoration of blood flow early after injury may lead to a shift towards apoptosis. It is important to elucidate what are the key mediators of apoptotic cell death after stroke, as inhibition of apoptosis may have therapeutic implications. There are two well described pathways that lead to apoptotic cell death; the caspase pathway and the more recently described caspase-independent pathway triggered by poly-ADP-ribose polymers (PARP) activation. Caspase-induced cell death is initiated by release of mitochondrial cytochrome c, formation of the cytosolic apoptosome, and activation of endonucleases leading to a multitude of small randomly cleaved DNA fragments. In contrast caspase-independent cell death is secondary to activation of apoptosis inducing factor (AIF). Mitochondrial AIF translocates to the nucleus, where it induces peripheral chromatin condensation, as well as characteristic high-molecular-weight (50 kbp) DNA fragmentation. Although caspase-independent cell death has been recognized for some time and is known to contribute to ischaemic injury, the upstream triggering events leading to activation of this pathway remain unclear. The two major theories are that ischaemia leads to nicotinamide adenine dinucleotide (NAD+) depletion and subsequent energy failure, or alternatively that cell death is directly triggered by a pro-apoptotic factor produced by activation of the DNA repair enzyme PARP. PARP activation is robust in the ischaemic brain producing variable lengths of poly-ADP-ribose (PAR) polymers as byproducts of PARP activation. PAR polymers may be directly toxic by triggering mitochondrial AIF release independently of NAD+ depletion. Recently, sex differences have been discovered that illustrate the importance of understanding these molecular pathways, especially as new therapeutics targeting apoptotic cell death are developed. Cell death in females proceeds primarily via caspase activation whereas caspase-independent mechanisms triggered by the activation of PARP predominate in the male brain. This review summarizes the current literature in an attempt to clarify the roles of NAD+ and PAR polymers in caspase-independent cell death, and discuss sex specific cell death to provide an example of the possible importance of these downstream mediators.

Indexed as

AnimalsApoptosisBrain IschemiaFemaleHumansMaleNADPoly Adenosine Diphosphate RiboseProteinsSex CharacteristicsNADPoly Adenosine Diphosphate Ribosepoly(ADP)-ribosylated proteinsProteins

Identifiers

PMID21091637
PMCPMC3135708
OpenAlexW1598898771

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.